183 related articles for article (PubMed ID: 8049634)
1. Quantitation of polycyclic aromatic hydrocarbons, 1-hydroxypyrene, and mutagenicity in urine of coal tar-treated psoriasis patients and untreated volunteers.
Santella RM; Nunes MG; Blaskovic R; Perera FP; Tang D; Beachman A; Lin JH; DeLeo VA
Cancer Epidemiol Biomarkers Prev; 1994 Mar; 3(2):137-40. PubMed ID: 8049634
[TBL] [Abstract][Full Text] [Related]
2. Biological monitoring of human exposure to coal tar. Urinary mutagenicity assays and analytical determination of polycyclic aromatic hydrocarbon metabolites in urine.
Clonfero E; Jongeneelen F; Zordan M; Levis AG
IARC Sci Publ; 1990; (104):215-22. PubMed ID: 2228119
[TBL] [Abstract][Full Text] [Related]
3. Biological monitoring of human exposure to coal tar. Urinary excretion of total polycyclic aromatic hydrocarbons, 1-hydroxypyrene and mutagens in psoriatic patients.
Clonfero E; Zordan M; Venier P; Paleologo M; Levis AG; Cottica D; Pozzoli L; Jongeneelen FJ; Bos RP; Anzion RB
Int Arch Occup Environ Health; 1989; 61(6):363-8. PubMed ID: 2744865
[TBL] [Abstract][Full Text] [Related]
4. Sensitivity of different bacterial assays in detecting mutagens in urine of humans exposed to polycyclic aromatic hydrocarbons.
Granella M; Clonfero E
Mutat Res; 1992 Jul; 268(1):131-7. PubMed ID: 1378179
[TBL] [Abstract][Full Text] [Related]
5. Smoking and dietary intake of polycyclic aromatic hydrocarbons as sources of interindividual variability in the baseline excretion of 1-hydroxypyrene in urine.
Van Rooij JG; Veeger MM; Bodelier-Bade MM; Scheepers PT; Jongeneelen FJ
Int Arch Occup Environ Health; 1994; 66(1):55-65. PubMed ID: 7927844
[TBL] [Abstract][Full Text] [Related]
6. Chromosomal alterations in peripheral blood lymphocytes, urinary mutagenicity and excretion of polycyclic aromatic hydrocarbons in six psoriatic patients undergoing coal tar therapy.
Sarto F; Zordan M; Tomanin R; Mazzotti D; Canova A; Cardin EL; Bezze G; Levis AG
Carcinogenesis; 1989 Feb; 10(2):329-34. PubMed ID: 2643486
[TBL] [Abstract][Full Text] [Related]
7. Mutagenic activity and polycyclic aromatic hydrocarbon levels in urine of humans exposed to therapeutical coal tar.
Clonfero E; Zordan M; Cottica D; Venier P; Pozzoli L; Cardin EL; Sarto F; Levis AG
Carcinogenesis; 1986 May; 7(5):819-23. PubMed ID: 3698208
[TBL] [Abstract][Full Text] [Related]
8. Exposure of iron foundry workers to polycyclic aromatic hydrocarbons: benzo(a)pyrene-albumin adducts and 1-hydroxypyrene as biomarkers for exposure.
Omland O; Sherson D; Hansen AM; Sigsgaard T; Autrup H; Overgaard E
Occup Environ Med; 1994 Aug; 51(8):513-8. PubMed ID: 7951774
[TBL] [Abstract][Full Text] [Related]
9. Urinary mutagenicity and genotoxic risk in children with psoriasis after therapeutic exposure to polycyclic aromatic hydrocarbons and ultraviolet radiation.
Borska L; Smejkalova J; Cerna M; Hamakova K; Kucera I; Kremlacek J; Pelikanova D; Fiala Z
Mutat Res; 2010 Feb; 696(2):144-7. PubMed ID: 20096371
[TBL] [Abstract][Full Text] [Related]
10. DNA adducts in skin biopsies and 1-hydroxypyrene in urine of psoriasis patients and healthy volunteers following treatment with coal tar.
Roelofzen JH; van der Valk PG; Godschalk R; Dettbarn G; Seidel A; Golsteijn L; Anzion R; Aben KK; van Schooten FJ; Kiemeney LA; Scheepers PT
Toxicol Lett; 2012 Aug; 213(1):39-44. PubMed ID: 21810456
[TBL] [Abstract][Full Text] [Related]
11. [The urinary mutagenicity test in monitoring exposure to aromatic polycyclic hydrocarbons in workers in the aluminum industry].
Granella M; Venier P; Zordan M; Clonfero E
Med Lav; 1992; 83(5):511-8. PubMed ID: 1297066
[TBL] [Abstract][Full Text] [Related]
12. Influence of metabolic genotype GSTM1 on levels of urinary mutagens in patients treated topically with coal tar.
Gabbani G; Pavanello S; Nardini B; Tognato O; Bordin A; Fornasa CV; Bezze G; Clonfero E
Mutat Res; 1999 Mar; 440(1):27-33. PubMed ID: 10095126
[TBL] [Abstract][Full Text] [Related]
13. Airborne exposure to polycyclic aromatic hydrocarbons (PAHs) and urinary excretion of 1-hydroxypyrene of carbon anode plant workers.
Petry T; Schmid P; Schlatter C
Ann Occup Hyg; 1996 Jun; 40(3):345-57. PubMed ID: 8694494
[TBL] [Abstract][Full Text] [Related]
14. [Longitudinal study of the excretion of 1-hydroxypyrene in urine after external treatment with coal tar].
Nenoff P; Richter B; Will W; Haustein UF
Hautarzt; 1997 Apr; 48(4):240-5. PubMed ID: 9206711
[TBL] [Abstract][Full Text] [Related]
15. Biological monitoring of polycyclic aromatic hydrocarbons. Metabolites in urine.
Jongeneelen FJ; Bos RP; Anzion RB; Theuws JL; Henderson PT
Scand J Work Environ Health; 1986 Apr; 12(2):137-43. PubMed ID: 3726495
[TBL] [Abstract][Full Text] [Related]
16. In vivo formation of mutagens by intraperitoneal administration of polycyclic aromatic hydrocarbons in animals during exposure to nitrogen dioxide.
Miyanishi K; Kinouchi T; Kataoka K; Kanoh T; Ohnishi Y
Carcinogenesis; 1996 Jul; 17(7):1483-90. PubMed ID: 8706253
[TBL] [Abstract][Full Text] [Related]
17. Aromatic DNA adducts in human white blood cells and skin after dermal application of coal tar.
Godschalk RW; Ostertag JU; Moonen EJ; Neumann HA; Kleinjans JC; van Schooten FJ
Cancer Epidemiol Biomarkers Prev; 1998 Sep; 7(9):767-73. PubMed ID: 9752984
[TBL] [Abstract][Full Text] [Related]
18. Highly increased urinary 1-hydroxypyrene excretion rate in patients with atopic dermatitis treated with topical coal tar.
Veenhuis RT; van Horssen J; Bos RP; Anzion RB; Van Der Valk PG
Arch Dermatol Res; 2002 Jul; 294(4):168-71. PubMed ID: 12111346
[TBL] [Abstract][Full Text] [Related]
19. A guidance value of 1-hydroxypyrene in urine in view of acceptable occupational exposure to polycyclic aromatic hydrocarbons.
Jongeneelen FJ
Toxicol Lett; 2014 Dec; 231(2):239-48. PubMed ID: 24831967
[TBL] [Abstract][Full Text] [Related]
20. Longitudinal study of excretion of metabolites of polycyclic aromatic hydrocarbons in urine from two psoriatic patients.
Hansen AM; Poulsen OM; Menné T
Acta Derm Venereol; 1993 Jun; 73(3):188-90. PubMed ID: 8105615
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
